查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1618854

胜肽合成市场：按产品、技术和最终用户划分 - 全球预测 2025-2030

Peptide Synthesis Market by Product (Equipment, Reagents, Services), Technology (Hybrid & Recombinant Technology, Solid-Phase Peptide Synthesis, Solution-Phase Synthesis), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年，胜肽合成市场价值为6.3671亿美元，预计2024年将达到6.8344亿美元，复合年增长率为7.84%，到2030年将达到10.8042亿美元。

肽合成是生物技术和医学中的关键过程，涉及肽的产生，肽是由氨基酸组成的化合物，在多种生物功能中发挥重要作用。肽合成的需求源自于药物开发、诊断和治疗应用，对于基于胜肽的药物设计、酵素研究和疫苗开发至关重要。其最终用途涵盖製药、生物技术和学术研究机构等产业。药物研发投资的增加、慢性病的流行以及固相和液相合成等合成技术的进步对胜肽合成市场的成长产生了显着影响。肽合成设备的自动化和小型化程度不断提高，透过提高效率和降低成本为市场扩张提供了巨大的机会。随着胜肽越来越多地用于自订治疗方法，个人化医疗存在巨大的机会。然而，高合成成本、复杂的监管核准以及胜肽稳定性和溶解度问题等挑战可能会阻碍市场成长。进一步的限制来自合成过程所需的技术专业知识和可扩展性问题。为了应对这些挑战，公司可以在合成器技术、胜肽修饰技术和胜肽溶解度解决方案等领域进行创新。此外，专注于开发稳定、长效胜肽製剂的研究可能会解决现有的稳定性问题。专注于增强肽的生物有效性和靶向能力可以进一步促进其治疗应用。该市场的另一个特点是竞争动态，老牌企业和新兴企业都注重创新以使其产品脱颖而出。因此，公司可以透过优先考虑与研究机构和生物技术公司的策略联盟和合作来加速市场渗透和成长，以利用胜肽疗法的新兴机会。

主要市场统计
基准年[2023] 63671万美元
预计年份 [2024] 6.8344亿美元
预测年份 [2030] 1,080,420,000 美元
复合年增长率（%） 7.84%

市场动态：揭示快速发展的胜肽合成市场的关键市场洞察

供需的动态交互作用正在改变胜肽合成市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 肽疗法的需求和应用不断增加
    • 各国的药物研究活动和资金增加
    • 化妆品产业对生物活性胜肽的需求不断增长
  • 市场限制因素
    • 缺乏标准的胜肽设计规则和规定
  • 市场机会
    • 开发先进的胜肽合成仪和胜肽设计技术
    • 胜肽在食品和食品保鲜的新应用
  • 市场挑战
    • 胜肽开发困难和胜肽不稳定

波特五力：驾驭胜肽合成市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解胜肽合成市场的外部影响

外部宏观环境因素在塑造多肽合成市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解胜肽合成市场的竞争状况

对肽合成市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵胜肽合成市场供应商绩效评估

FPNV定位矩阵是评估胜肽合成市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了胜肽合成市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对肽合成市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 肽疗法的需求和应用不断增加
      • 整个经济领域的药物研究活动和资金增加
      • 化妆品产业对生物活性胜肽的需求增加
    • 抑制因素
      • 缺乏标准的胜肽设计规则和规定
    • 机会
      • 先进胜肽合成设备及胜肽设计技术的开发
      • 胜肽在食品和食品保鲜的新应用
    • 任务
      • 胜肽开发困难和胜肽不稳定
  • 市场区隔分析
    • 产品：在合成过程中增加使用试剂形成胜肽键
    • 技术：胜肽的高产量和纯度增加了杂交和重组技术的潜力
    • 最终用户：製药和生物製药公司扩大胜肽合成在新药发现的应用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章胜肽合成市场：副产品

  • 装置
    • 层析法设备
    • 冷冻干燥设备
    • 胜肽合成仪
  • 试剂
    • 胺基酸
    • 基础树脂
    • 胜肽耦合试剂
    • 胜肽标记试剂
  • 服务

第七章胜肽合成市场：依技术分类

  • 杂交和重组技术
  • 固相胜肽合成
  • 溶液相合成

第八章胜肽合成市场：依最终用户分类

  • 学术研究所
  • 合约开发和製造组织/合约研究组织
  • 製药和生物技术公司

第九章美洲胜肽合成市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太多胜肽合成市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲胜肽合成市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Biosynth 透过收购 Pepceuticals 扩大胜肽合成产品
    • 金斯瑞扩大胜肽产能，包括新抗原胜肽和 API
    • Mesa Labs 收购 Belyntic 的胜肽精製业务
  • 战略分析和建议

公司名单

  • 2B Scientific Limited
  • AAPPTec
  • ABclonal, Inc.
  • Advanced ChemTech
  • Almac Group Limited
  • AmbioPharm Inc.
  • AnaSpec Inc.
  • Bachem AG
  • Biocon Limited
  • Biosynth Ltd.
  • Biotage
  • CEM Corporation
  • CPC Scientific Inc.
  • Creative Diagnostics
  • Creative Peptides
  • CSBio
  • Enamine Ltd.
  • GenScript Biotech Corporation
  • Gyros Protein Technologies AB
  • Hybio Pharmaceutical Co., Ltd.
  • JPT Peptide Technologies GmbH by TheraCode GmbH
  • Kaneka Corporation
  • LifeTein LLC
  • Merck KGaA
  • New England BioGroup, LLC
  • Novo Nordisk A/S
  • PolyPeptide Group AG
  • Thermo Fisher Scientific Inc.
  • USV Private Limited
Product Code: MRR-431388EE3B9B

The Peptide Synthesis Market was valued at USD 636.71 million in 2023, expected to reach USD 683.44 million in 2024, and is projected to grow at a CAGR of 7.84%, to USD 1,080.42 million by 2030.

Peptide synthesis, a pivotal process in biotechnology and pharmaceuticals, involves the creation of peptides, compounds comprised of amino acids that play critical roles in various biological functions. The necessity of peptide synthesis stems from its applications in drug development, diagnostics, and therapeutics, making it vital for designing peptide-based drugs, enzyme research, and developing vaccines. Its end-use scope spans across industries such as pharmaceuticals, biotechnology, and academic research institutions. Growth in the peptide synthesis market is significantly influenced by increased investment in pharmaceutical R&D, rising prevalence of chronic diseases, and advancements in synthesis technologies such as solid-phase and liquid-phase synthesis. Enhanced automation and miniaturization in peptide synthesizers present considerable opportunities for market expansion by improving efficiency and reducing costs. A major opportunity lies in personalized medicine, as peptides increasingly are used for custom therapeutic approaches. However, challenges such as the high cost of synthesis, complex regulatory approvals, and issues with peptide stability and solubility can impede market growth. Limitations further arise from the technical expertise required for synthesis processes and scalability concerns. To counter these challenges, companies can innovate in areas like synthesizer technology, peptide modification techniques, and peptide solubility solutions. Additionally, research focusing on developing stable, long-acting peptide formulations could address existing stability issues. Focusing on enhancing bioavailability and targeting capabilities of peptides can further drive their therapeutic applications. The market is also characterized by competitive dynamics with both established players and startups focusing on innovation to differentiate their offerings. Consequently, businesses should prioritize strategic partnerships and collaborations with research institutions and biotech firms to take advantage of emerging opportunities in peptide therapeutics, thereby fostering accelerated market penetration and growth.

KEY MARKET STATISTICS
Base Year [2023] USD 636.71 million
Estimated Year [2024] USD 683.44 million
Forecast Year [2030] USD 1,080.42 million
CAGR (%) 7.84%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Peptide Synthesis Market

The Peptide Synthesis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Higher need and applications of peptide therapeutics
    • Increase in pharmaceutical research activities and funding across economies
    • Growing demand for bioactive peptides from the cosmetics industry
  • Market Restraints
    • Lack of standard peptide design rules and regulations
  • Market Opportunities
    • Development of advanced peptide synthesizers and technologies for peptide design
    • Emerging applications of peptides in nutraceuticals and food preservation
  • Market Challenges
    • Difficulty in development of peptides and instability of the peptides

Porter's Five Forces: A Strategic Tool for Navigating the Peptide Synthesis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Peptide Synthesis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Peptide Synthesis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Peptide Synthesis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Peptide Synthesis Market

A detailed market share analysis in the Peptide Synthesis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Peptide Synthesis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Peptide Synthesis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Peptide Synthesis Market

A strategic analysis of the Peptide Synthesis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Peptide Synthesis Market, highlighting leading vendors and their innovative profiles. These include 2B Scientific Limited, AAPPTec, ABclonal, Inc., Advanced ChemTech, Almac Group Limited, AmbioPharm Inc., AnaSpec Inc., Bachem AG, Biocon Limited, Biosynth Ltd., Biotage, CEM Corporation, CPC Scientific Inc., Creative Diagnostics, Creative Peptides, CSBio, Enamine Ltd., GenScript Biotech Corporation, Gyros Protein Technologies AB, Hybio Pharmaceutical Co., Ltd., JPT Peptide Technologies GmbH by TheraCode GmbH, Kaneka Corporation, LifeTein LLC, Merck KGaA, New England BioGroup, LLC, Novo Nordisk A/S, PolyPeptide Group AG, Thermo Fisher Scientific Inc., and USV Private Limited.

Market Segmentation & Coverage

This research report categorizes the Peptide Synthesis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Equipment, Reagents, and Services. The Equipment is further studied across Chromatography Equipment, Lyophilizers, and Peptide Synthesizers. The Reagents is further studied across Amino Acids, Base Resins, Peptide Coupling Reagents, and Peptide Labeling Reagents.
  • Based on Technology, market is studied across Hybrid & Recombinant Technology, Solid-Phase Peptide Synthesis, and Solution-Phase Synthesis.
  • Based on End User, market is studied across Academic & Research Institutes, Contract Development & Manufacturing Organization/Contract Research Organization, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Higher need and applications of peptide therapeutics
      • 5.1.1.2. Increase in pharmaceutical research activities and funding across economies
      • 5.1.1.3. Growing demand for bioactive peptides from the cosmetics industry
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of standard peptide design rules and regulations
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of advanced peptide synthesizers and technologies for peptide design
      • 5.1.3.2. Emerging applications of peptides in nutraceuticals and food preservation
    • 5.1.4. Challenges
      • 5.1.4.1. Difficulty in development of peptides and instability of the peptides
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Growing usage of reagents for forming peptide bonds during synthesis
    • 5.2.2. Technology: Rising potential of hybris & recombinant technology as it offers high peptide yield and purity
    • 5.2.3. End-User: Expanding usage of peptide synthesis by pharmaceutical & biopharmaceutical companies for drug discovery
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Peptide Synthesis Market, by Product

  • 6.1. Introduction
  • 6.2. Equipment
    • 6.2.1. Chromatography Equipment
    • 6.2.2. Lyophilizers
    • 6.2.3. Peptide Synthesizers
  • 6.3. Reagents
    • 6.3.1. Amino Acids
    • 6.3.2. Base Resins
    • 6.3.3. Peptide Coupling Reagents
    • 6.3.4. Peptide Labeling Reagents
  • 6.4. Services

7. Peptide Synthesis Market, by Technology

  • 7.1. Introduction
  • 7.2. Hybrid & Recombinant Technology
  • 7.3. Solid-Phase Peptide Synthesis
  • 7.4. Solution-Phase Synthesis

8. Peptide Synthesis Market, by End User

  • 8.1. Introduction
  • 8.2. Academic & Research Institutes
  • 8.3. Contract Development & Manufacturing Organization/Contract Research Organization
  • 8.4. Pharmaceutical & Biotechnology Companies

9. Americas Peptide Synthesis Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Peptide Synthesis Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Peptide Synthesis Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Biosynth Extends Peptide Synthesis Offering With Pepceuticals Acquisition
    • 12.3.2. GenScript Expands Peptide Production Capabilities to Include Neoantigen Peptides and APIs
    • 12.3.3. Mesa Labs Acquires Belyntic's Peptide Purification Business
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 2B Scientific Limited
  • 2. AAPPTec
  • 3. ABclonal, Inc.
  • 4. Advanced ChemTech
  • 5. Almac Group Limited
  • 6. AmbioPharm Inc.
  • 7. AnaSpec Inc.
  • 8. Bachem AG
  • 9. Biocon Limited
  • 10. Biosynth Ltd.
  • 11. Biotage
  • 12. CEM Corporation
  • 13. CPC Scientific Inc.
  • 14. Creative Diagnostics
  • 15. Creative Peptides
  • 16. CSBio
  • 17. Enamine Ltd.
  • 18. GenScript Biotech Corporation
  • 19. Gyros Protein Technologies AB
  • 20. Hybio Pharmaceutical Co., Ltd.
  • 21. JPT Peptide Technologies GmbH by TheraCode GmbH
  • 22. Kaneka Corporation
  • 23. LifeTein LLC
  • 24. Merck KGaA
  • 25. New England BioGroup, LLC
  • 26. Novo Nordisk A/S
  • 27. PolyPeptide Group AG
  • 28. Thermo Fisher Scientific Inc.
  • 29. USV Private Limited

LIST OF FIGURES

  • FIGURE 1. PEPTIDE SYNTHESIS MARKET RESEARCH PROCESS
  • FIGURE 2. PEPTIDE SYNTHESIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. PEPTIDE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. PEPTIDE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PEPTIDE SYNTHESIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PEPTIDE SYNTHESIS MARKET DYNAMICS
  • TABLE 7. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY CHROMATOGRAPHY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY LYOPHILIZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PEPTIDE SYNTHESIZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY AMINO ACIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY BASE RESINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PEPTIDE COUPLING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PEPTIDE LABELING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY HYBRID & RECOMBINANT TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY SOLID-PHASE PEPTIDE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION/CONTRACT RESEARCH ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL PEPTIDE SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES PEPTIDE SYNTHESIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM PEPTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 237. PEPTIDE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 238. PEPTIDE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2023